Hem/Onc @Point of Care

Hematology & Oncology

Разработчик: At Point of Care
Скачивания
Доход

Описание

Hematology/Oncology @Point of Care™ is a clinical decision-making mobile platform. It provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed, keep track of their patients—enabling better decisions, better outcomes, and better care.
Featuring @sk Cognitive AI, clinicians use Hematology/Oncology @Point of Care to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. The @sk Cognitive, confidence-rated answers happen more quickly to efficiently incorporate best treatment options and decisions are made faster to improve patient outcomes at the point of care.
Hematology/Oncology @Point of Care is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
• Receive detailed information regarding your patients' health such as: Medications and treatments; Symptoms and side effects; Charts that record test results, medication adherence, and more
• Voice-activate commands for Watson, Patient Access and Clinical resources
• Read-aloud feature for hands-free listening to medical texts
• App Prescriber lets you prescribe one of our many patient apps to your patients
Скрыть Показать больше...

Скриншоты

Hem/Onc @Point of Care Частые Вопросы

  • Приложение Hem/Onc @Point of Care бесплатное?

    Да, Hem/Onc @Point of Care полностью бесплатное и не содержит встроенных покупок или подписок.

  • Является ли Hem/Onc @Point of Care фейковым или мошенническим?

    Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.

    Спасибо за ваш голос

  • Сколько стоит Hem/Onc @Point of Care?

    Приложение Hem/Onc @Point of Care бесплатное.

  • Сколько зарабатывает Hem/Onc @Point of Care?

    Чтобы получить оценку дохода приложения Hem/Onc @Point of Care и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.

Оценки пользователей
Приложение еще не оценено в Венгрия.
История оценок

Hem/Onc @Point of Care Отзывы Пользователей

Нет отзывов в Венгрия
Приложение пока не имеет отзывов в Венгрия.

Оценки

История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Приложение еще не было в топах

Hem/Onc @Point of Care Конкуренты

Name
HemeOncBuddy
hemeonc trials
Research To Practice
Manual of Clinical Oncology
with Expert Recommentations
Cancer Pharmacology Manual
Anticancer Oncology Drug Guide
Physicians Cancer Chemotherapy
Clinical Therapy Drug Guide
Williams Manual of Hematology
With interactive flowcharts
ASH Pocket Guides
Hematology app
Hematology
ALTAI Oncology
Protocols, Staging, and More
ASCO-SEP®
ASCO Self-Evaluation Program

Hem/Onc @Point of Care Установки

30дн.

Hem/Onc @Point of Care Доход

30дн.

Hem/Onc @Point of Care Доходы и Загрузки

Получите ценные инсайты о производительности Hem/Onc @Point of Care с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.

Информация о приложении

This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.